Coston, McIsaac & Partners
- SEC CIK
- 0001945037
- Latest filing
- Aug 12, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Coston, McIsaac & Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,551
- Value
- $231.0K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,551 | $231.0K | <0.1% | +80+3.2% | Added | Holders |
| Q1 2026 | 2,471 | $253.0K | 0.1% | −101−3.9% | Reduced | Holders |
| Q4 2025 | 2,572 | $322.0K | 0.1% | +144+5.9% | Added | Holders |
| Q3 2025 | 2,428 | $325.0K | 0.1% | +23+1.0% | Added | Holders |
| Q2 2025 | 2,405 | $327.0K | 0.1% | −34−1.4% | Reduced | Holders |
| Q1 2025 | 2,439 | $323.0K | 0.1% | −298−10.9% | Reduced | Holders |
| Q4 2024 | 2,737 | $309.0K | 0.1% | +12+0.4% | Added | Holders |
| Q3 2024 | 2,725 | $310.0K | 0.1% | +371+15.8% | Added | Holders |
| Q2 2024 | 2,354 | $244.0K | 0.1% | +586+33.1% | Added | Holders |
| Q1 2024 | 1,768 | $201.0K | 0.1% | +513+40.9% | Added | Holders |
| Q4 2023 | 1,255 | $138.0K | <0.1% | +227+22.1% | Added | Holders |
| Q3 2023 | 1,028 | $99.0K | <0.1% | +73+7.6% | Added | Holders |
| Q2 2023 | 955 | $104.0K | <0.1% | +100+11.7% | Added | Holders |
| Q1 2023 | 855 | $86.0K | <0.1% | +2+0.2% | Added | Holders |
| Q4 2022 | 853 | $93.0K | <0.1% | +2+0.2% | Added | Holders |
| Q3 2022 | 851 | $82.0K | <0.1% | +1+0.1% | Added | Holders |
| Q2 2022 | 850 | $92.0K | 0.1% | – | No prior filing | Holders |